ScreenerHero

CUVLClinuvel Pharmaceuticals Limited American Depositary Shares

NAS · US · Healthcare · Biotechnology · clinuvel.com
7.800USDMkt Cap: 393.34M $P/E: 16.96

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap393.34M $
Enterprise Value158.59M $
Revenue (TTM)96.30M $
Gross Profit79.14M $
Net Income (TTM)36.17M $
Revenue/Share1.921 USD
Last Price7.800 USD
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)16.96
P/E (Forward)—
PEG—
EV/EBITDA3.63
EV/Revenue1.65
P/S4.08
P/B2.22
EPS (TTM)0.46
EPS (Forward)—
52W Range
7.46065% of range7.980
52W High7.980 USD
52W Low7.460 USD
Profitability
Gross Margin83.29%
Oper. Margin36.59%
EBITDA Margin45.36%
Profit Margin38.07%
ROE15.02%
ROA13.31%
Growth
Revenue Growth3.60%
Earnings Growth-26.30%
Cash Flow & Leverage
Operating CF40.47M $
CapEx (TTM)298.57K $
FCF Margin33.43%
FCF Yield8.19%
Net Debt-232.68M $
Net Debt/EBITDA-5.33
Balance Sheet
Debt/Equity0.00
Current Ratio14.64
Quick Ratio13.98
Book Value/Sh3.515 USD
Cash/Share4.645 USD
Dividends
Fwd Div Rate0.0300 USD
Trail. Div Rate0.0500 USD
Div. Yield0.42%
5Y Avg Yield0.29%
Payout Ratio7.77%
Ex-Div DateSep 8, 2025
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.50.43M
Float43.65M
Insiders0.00%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short127
Technical
SMA 507.030 (+10.9%)
SMA 2007.293 (+6.9%)
Beta0.57
S&P 52W Chg19.18%
Avg Vol (30d)26.40K
Avg Vol (10d)5.21K
Technical Indicators
RSI (14)68.3
MACD0.1137
MACD Signal-0.0056
MACD Hist.+0.1193
BB Upper7.604 USD
BB Middle6.920 USD
BB Lower6.235 USD
BB Width19.78%
ATR (14)0.3311 USD
Vol Ratio (20d)0.00x